Literature DB >> 8133870

Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver-transplant recipients.

B Dousset, F Conti, D Houssin, Y Calmus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8133870     DOI： 10.1056/NEJM199404213301618

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Hepatitis C and bile duct loss.

Authors:  R D Goldin; N K Patel; H C Thomas
Journal:  J Clin Pathol       Date:  1996-10       Impact factor: 3.411

2.  Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon.

Authors:  A Jain; A J Demetris; R Manez; A C Tsamanadas; D Van Thiel; J Rakela; T E Starzl; J J Fung
Journal:  Liver Transpl Surg       Date:  1998-05

Review 3.  Cytokine-induced autoimmune disorders.

Authors:  P Miossec
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 4.  Late liver function test abnormalities post-adult liver transplantation: a review of the etiology, investigation, and management.

Authors:  Oscar Mitchell; Arif M Cosar; Mohammad U Malik; Ahmet Gurakar
Journal:  Hepatol Int       Date:  2015-11-24       Impact factor: 6.047

5.  Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report.

Authors:  Zonghao Zhao; Lei Bao; Xiaolan Yu; Chuanlong Zhu; Jing Xu; Yu Wang; Ming Yin; Yi Li; Wenting Li
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.